AMALTHEA: Prospective, Single‐Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First‐Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer
暂无分享,去创建一个
G. Aravantinos | C. Petraki | G. Fountzilas | G. Pentheroudakis | A. Voutsina | D. Pectasides | D. Bafaloukos | V. Karavasilis | A. Kalogera‐Fountzila | J. Sgouros | V. Kotoula | E. Samantas | I. Efstratiou | G. Koumakis | E. Vrettou | C. Poulios | K. Laschos | G. Koliou | N. Kentepozidis | I. Souglakos | L. Kalogeropoulou | A. Goudopoulou | I. Tikas | G. Zarkavelis | A. Kalogera-Fountzila | Lydia Kalogeropoulou